Y
Ying Wang
Researcher at McMaster University
Publications - 20
Citations - 1183
Ying Wang is an academic researcher from McMaster University. The author has contributed to research in topics: Meta-analysis & Medicine. The author has an hindex of 10, co-authored 17 publications receiving 622 citations. Previous affiliations of Ying Wang include Second Military Medical University & Capital Medical University.
Papers
More filters
Journal ArticleDOI
Drug treatments for covid-19: living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Long Ge,Dena Zeraatkar,Ariel Izcovich,Elena Kum,Hector Pardo-Hernandez,Anila Qasim,Juan Pablo Diaz Martinez,Bram Rochwerg,Francois Lamontagne,Mi Ah Han,Qin Liu,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Bo Fang,Carmen Fang,Signe Flottorp,Signe Flottorp,Farid Foroutan,Farid Foroutan,Maryam Ghadimi,Diane Heels-Ansdell,Kimia Honarmand,Liangying Hou,Xiaorong Hou,Quazi Ibrahim,Assem M. Khamis,Bonnie Lam,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,John Neary,Gabriel Rada,Irbaz Bin Riaz,Behnam Sadeghirad,Nigar Sekercioglu,Lulu Sheng,Ashwini Sreekanta,Charlotte Switzer,Britta Tendal,Lehana Thabane,George Tomlinson,Tari Turner,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +61 more
TL;DR: Glucocorticoids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care and the effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.
Journal ArticleDOI
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Zhikang Ye,Ying Wang,Luis Enrique Colunga-Lozano,Manya Prasad,Wimonchat Tangamornsuksan,Bram Rochwerg,Liang Yao,Shahrzad Motaghi,Rachel Couban,Maryam Ghadimi,Malgorzata M. Bala,Huda Gomaa,Fang Fang,Yingqi Xiao,Gordon H. Guyatt +14 more
TL;DR: Corticosteroids may reduce mortality for patients with COVID-19 and ARDS and Randomized controlled trials in CAP suggest that corticosteroid may reduce deaths, and may increase hyperglycemia.
Journal ArticleDOI
Prophylaxis against covid-19: living systematic review and network meta-analysis.
Jessica J Bartoszko,Reed A C Siemieniuk,Elena Kum,Anila Qasim,Dena Zeraatkar,Long Ge,Mi Ah Han,Behnam Sadeghirad,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Andrea Darzi,Tahira Devji,Maryam Ghadimi,Kimia Honarmand,Ariel Izcovich,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,John Neary,Hector Pardo-Hernandez,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Britta Tendal,Lehana Thabane,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +40 more
TL;DR: In this paper, the authors compared the effects of drug prophylaxis on SARS-CoV-2 infection and covid-19 using living systematic review and network meta-analysis.
Journal ArticleDOI
Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.
Zhikang Ye,Zhikang Ye,Annika Reintam Blaser,Lyubov Lytvyn,Ying Wang,Gordon H. Guyatt,J Stephen Mikita,Jamie Roberts,Thomas Agoritsas,Sonja Bertschy,Filippo Boroli,Julie Camsooksai,Bin Du,Anja Fog Heen,Jianyou Lu,José M. Mella,Per Olav Vandvik,Robert Wise,Robert Wise,Yue Zheng,Lihong Liu,Reed A C Siemieniuk +21 more
TL;DR: In most critically ill patients, the reduction in clinically important gastrointestinal bleeding from gastric acid suppressants is closely balanced with the possibility of pneumonia.
Journal ArticleDOI
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Juan Pablo Diaz Martinez,Elena Kum,Anila Qasim,Dena Zeraatkar,Ariel Izcovich,Sophia O Mangala,Long Ge,Mi Ah Han,Thomas Agoritsas,Donald M. Arnold,Camila Ávila,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Farid Foroutan,Maryam Ghadimi,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Anna Miroshnychenko,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Per Olav Vandvik,Robin W.M. Vernooij,Ying Wang,Liang Yao,Gordon H. Guyatt,Romina Brignardello-Petersen +36 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19), with pairwise meta-analysis for outcomes with insufficient data.